# PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer

> **NCT00669292** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Wakayama Medical University** · enrollment: 29 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **BIOLOGICAL:** URLC10-177, TTK-567, CpG-7909

## Key facts

- **NCT ID:** NCT00669292
- **Lead sponsor:** Wakayama Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-11
- **Primary completion:** 2009-11
- **Final completion:** —
- **Target enrollment:** 29 (ESTIMATED)
- **Last updated:** 2010-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00669292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00669292, "PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00669292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*